Download presentation
Presentation is loading. Please wait.
Published byBeatrix Walters Modified over 6 years ago
1
Treatment Options for Post-MI patients with LVD – are all ACE Inhibitors Equal?
2
Program Overview
3
Influence of LV Dysfunction on Post-MI Outcomes
4
Predictive Value of Markers of Organ Damage
5
Treatment Options: Targeting Neurohormonal Pathways
6
ESC Guideline Recommendations
7
Distinguishing Between Agents in the Same Class: Considerations
8
Class Effect: ACE Inhibitors Post-MI
9
SMILE: Overview
10
SMILE: Rationale
11
Cardioprotective Effects of Zofenopril
12
Effects of ACE Inhibitors on Endothelial Stress
13
SMILE-4: Distinguishing Between ACE Inhibitors in Combination With Aspirin
14
SMILE-4: Subanalysis in Hypertensive Patients
15
SMILE-ISCHEMIA: Analysis of Patients With Preserved LV Function
16
Conclusions
17
Abbreviations
18
Abbreviations
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.